Orthobiologics

Regentis Biomaterials expanded the SAGE clinical trial of GelrinC to 11 U.S. sites. The investigational device is in evaluation to regrow knee...

Kuros Biosciences obtained U.S. Patent No. 10,064,892, "Method for producing an osteoinductive calcium phosphate and products thus obtained"....

Bone Therapeutics' first efficacy study of the JTA-004 viscosupplement to treat knee OA showed that a single injection delivered higher...

Bone Solutions announced completion of the first 250 cases of implanted OsteoCrete® magnesium-based bone void filler....

The first patient has been treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in...

Baxter was granted FDA 510(k) clearance to market ALTAPORE Bioactive Bone Graft as an autograft extender in posterolateral spinal fusion....

LifeNet Health commenced limited launch of PliaFX® Prime precision-engineered cortical fibers....

Synergy Biomedical received FDA 510(k) clearance to market BIOSPHERE® FLEX bone graft. ...

NuVasive commenced U.S. launch of three new biologic products for spine, including traditional bone allograft, an amniotic membrane and new...

Tobra Medical commenced U.S. launch of the Tobra Bone Basket to maximize collection of autograft bone....